Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/118466
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGonzález-Sarrías, Antonio-
dc.contributor.authorCombet, Emilie-
dc.contributor.authorPinto, Paula-
dc.contributor.authorMena, Pedro-
dc.contributor.authorDall'Asta, Margherita-
dc.contributor.authorGarcia Aloy, Mar-
dc.contributor.authorRodriguez-Mateos, Ana-
dc.contributor.authorGibney, Eileen R.-
dc.contributor.authorDumont, Julie-
dc.contributor.authorMassaro, Marika-
dc.contributor.authorSánchez Meca, Julio-
dc.contributor.authorMorand, Christine-
dc.contributor.authorGarcía-Conesa, María Teresa-
dc.date.accessioned2017-12-04T16:03:10Z-
dc.date.available2017-12-04T16:03:10Z-
dc.date.issued2017-07-10-
dc.identifier.issn2072-6643-
dc.identifier.urihttps://hdl.handle.net/2445/118466-
dc.description.abstractSeveral randomized controlled trials (RCTs) and meta-analyses support the benefits of flavanols on cardiometabolic health, but the factors affecting variability in the responses to these compounds have not been properly assessed. The objectives of this meta-analysis were to systematically collect the RCTs-based-evidence of the effects of flavanol-containing tea, cocoa and apple products on selected biomarkers of cardiometabolic risk and to explore the influence of various factors on the variability in the responses to the consumption of these products. A total of 120 RCTs were selected. Despite a high heterogeneity, the intake of the flavanol-containing products was associated using a random model with changes (reported as standardized difference in means (SDM)) in body mass index (−0.15, p < 0.001), waist circumference (−0.29, p < 0.001), total-cholesterol (−0.21, p < 0.001), LDL-cholesterol (−0.23, p < 0.001), and triacylglycerides (−0.11, p = 0.027), and with an increase of HDL-cholesterol (0.15, p = 0.005). Through subgroup analyses, we showed the influence of baseline-BMI, sex, source/form of administration, medication and country of investigation on some of the outcome measures and suggest that flavanols may be more effective in specific subgroups such as those with a BMI ≥ 25.0 kg/m2, non-medicated individuals or by specifically using tea products. This meta-analysis provides the first robust evidence of the effects induced by the consumption of flavanol-containing tea, cocoa and apple products on weight and lipid biomarkers and shows the influence of various factors that can affect their bioefficacy in humans. Of note, some of these effects are quantitatively comparable to those produced by drugs, life-style changes or other natural products. Further, RCTs in well-characterized populations are required to fully comprehend the factors affecting inter-individual responses to flavanol and thereby improve flavanols efficacy in the prevention of cardiometabolic disorders.-
dc.format.extent28 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/nu9070746-
dc.relation.ispartofNutrients, 2017, vol. 9, num. 7, p. 746-
dc.relation.urihttps://doi.org/10.3390/nu9070746-
dc.rightscc-by (c) González-Sarrías, Antonio et al., 2017-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)-
dc.subject.classificationNutrició-
dc.subject.classificationTe-
dc.subject.classificationCacau-
dc.subject.classificationPomes-
dc.subject.classificationFlavonoides-
dc.subject.classificationTrastorns del metabolisme-
dc.subject.classificationMalalties cardiovasculars-
dc.subject.classificationMetaanàlisi-
dc.subject.otherNutrition-
dc.subject.otherTea-
dc.subject.otherCocoa-
dc.subject.otherApples-
dc.subject.otherFlavonoids-
dc.subject.otherDisorders of metabolism-
dc.subject.otherCardiovascular diseases-
dc.subject.otherMeta-analysis-
dc.titleA systematic review and meta-analysis of the effects of flavanol-containing tea, cocoa and apple products on selected cardiometabolic risk biomarkers: exploring the factors responsible for variability in their efficacy-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec672807-
dc.date.updated2017-12-04T16:03:10Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)

Files in This Item:
File Description SizeFormat 
672807.pdf484.42 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons